Litcius/Paper detail

Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)

Devalingam Mahalingam, Siqi Chen, Ping Xie, Houra Loghmani, Thomas Heineman, Aparna Kalyan, Sheetal Kircher, Irene Helenowski, Xinlei Mi, Victoria Maurer, Matt Coffey, Mary F. Mulcahy, Al B. Benson, Bin Zhang

2023British Journal of Cancer21 citationsDOIOpen Access PDF

Topics & Concepts

PembrolizumabMedicineInternal medicineChemotherapyOncologyCD8ImmunotherapyImmune systemGastroenterologyRegimenChemotherapy regimenImmunologyCancerCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchImmunotherapy and Immune Responses